Literature DB >> 20450852

Current diagnostic and prognostic assessment of pulmonary Hypertension.

Pilar Escribano Subias1, Joan Albert Barberà Mir, Verónica Suberviola.   

Abstract

Recently, our view of pulmonary hypertension has been changed by the significant progress made in understanding the pathobiology, epidemiology and prognosis of the disease. The increasing number of different conditions now associated with pulmonary hypertension and the appearance of new diagnostic techniques have led to a need for a systematic diagnostic approach and a new disease classification. This review article presents an update on developments in the epidemiology and pathobiology of pulmonary hypertension, on changes in the clinical classification of the disease, and on alterations in the diagnostic algorithm. In addition, it contains detailed descriptions of the treatment recommended for patients in whom an elevated systolic pulmonary pressure is discovered on echocardiography, of the differential diagnosis of pulmonary arterial hypertension and pulmonary hypertension associated with left heart disease, and of multifactorial approaches to determining prognosis, which are three of the most actively debated topics today. Finally, a care program for patients with pulmonary arterial hypertension is proposed.

Entities:  

Mesh:

Year:  2010        PMID: 20450852     DOI: 10.1016/s1885-5857(10)70120-1

Source DB:  PubMed          Journal:  Rev Esp Cardiol        ISSN: 0300-8932            Impact factor:   4.753


  4 in total

1.  Hemodynamic assessment of pulmonary hypertension.

Authors:  Juan C Grignola
Journal:  World J Cardiol       Date:  2011-01-26

2.  High levels of serum lactate dehydrogenase correlate with the severity and mortality of idiopathic pulmonary arterial hypertension.

Authors:  En-Ci Hu; Jian-Guo He; Zhi-Hong Liu; Xin-Hai Ni; Ya-Guo Zheng; Qing Gu; Zhi-Hui Zhao; Chang-Ming Xiong
Journal:  Exp Ther Med       Date:  2015-03-20       Impact factor: 2.447

3.  Comprehensive Exercise Capacity and Quality of Life Assessments Predict Mortality in Patients with Pulmonary Arterial Hypertension.

Authors:  Yi-Jen Chen; Hung-Pin Tu; Chia-Ling Lee; Wei-Chun Huang; Jin-Shiou Yang; Cyuan-Fong Li; Chia-Hsin Chen; Ko-Long Lin
Journal:  Acta Cardiol Sin       Date:  2019-01       Impact factor: 2.672

Review 4.  Calcium channel blockers for pulmonary arterial hypertension.

Authors:  Zhiyu Fan; Yuanjing Chen; Hanmin Liu
Journal:  Cochrane Database Syst Rev       Date:  2015-09-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.